Drugs / Nectero EAST System
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06001918 | Oct 2023 → Jun 2028 expected | abdominal aortic aneurysm | Nectero Medical, Inc. | Recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2023-11-01 | Nectero Medical, Inc. | Regulatory Nectero Therapeutics Granted Breakthrough Therapy Designation for the Nectero EAST® System to Treat Infrarenal AAA necterotherapeutics.com ↗
Nectero Therapeutics, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System to treat patients with infrarenal AAAs, maximum diameter 3.5 – 5.0cm. |
| 2023-08-24 | Nectero Medical, Inc. | Regulatory Nectero Therapeutics Receives FDA Fast Track Designation for Nectero EAST® System necterotherapeutics.com ↗
today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System to treat patients with infrarenal AAAs, maximum diameter 3.5 – 5.0cm. |
| 2023-07-24 | Nectero Medical, Inc. | Regulatory Nectero Therapeutics Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms necterotherapeutics.com ↗ |
All press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-11-01 | Nectero Medical, Inc. | Nectero Therapeutics Granted Breakthrough Therapy Designation for the Nectero EAST® System to Treat Infrarenal AAA necterotherapeutics.com ↗ |
| 2023-08-24 | Nectero Medical, Inc. | Nectero Therapeutics Receives FDA Fast Track Designation for Nectero EAST® System necterotherapeutics.com ↗ |
| 2023-07-24 | Nectero Medical, Inc. | Nectero Therapeutics Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms necterotherapeutics.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nectero EAST System | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06001918 ↗ |
| Route | Other | “endovascular procedure with the Nectero EAST system” NCT06001918 ↗ |